Nyxoah SA

NYXH NASDAQ Santé & Biotech Europe
3.08 $
5.48 %

Nyxoah conçoit et développe des dispositifs médicaux implantables innovants pour le traitement de l'apnée du sommeil, basés sur la stimulation neurochirurgicale.

Performance & Momentum

6 Months 38.40 %
1 Year 49.17 %
3 Years 61.26 %
5 Years 86.70 %

Similar stocks to Nyxoah SA

Anantys Community

Be the first to share your analysis on Nyxoah SA.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases